{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:14:16Z","timestamp":1760044456908,"version":"3.40.5"},"reference-count":47,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"abstract":"<jats:title>This Policy Statement was retired December 2015.<\/jats:title>\n               <jats:p>Substance abuse, specifically the use of illicit drugs that are administered intravenously, continues to play a role in the transmission of human immunodeficiency virus type 1 (HIV-1) among adolescents and young adults (youth). Risks of HIV-1 infection may result from direct exposure to contaminated blood through sharing of injection drug equipment and from unsafe sexual practices (while under the influence of drugs and\/or in exchange for drugs). Reducing the risk of HIV-1 infection that is associated with illicit drug use requires prevention education and prompt engagement in treatment. Providing patients with education, instruction on decontamination of used injection drug equipment, improved access to sterile syringes and needles, and postexposure prophylaxis may decrease their risk of acquiring HIV-1 infection. Pediatricians should assess risk behaviors as part of every health care encounter, including queries about tobacco, alcohol, and marijuana use. The risks and benefits of postexposure prophylaxis with antiretroviral drugs should be considered for youth with a single recent (within 72 hours) high-risk exposure to HIV-1 through sharing needles\/syringes with an HIV-1\u2013infected individual or having unprotected intercourse with an individual who engages in injection drug use. Such prophylaxis must be accompanied by risk-reduction counseling, appropriate referrals for treatment, and evaluation for pregnancy and associated sexually transmitted infections. There is an urgent need for more substance-abuse prevention and treatment programs, legislation that facilitates unencumbered access to sterile syringes, and expedient availability of reproductive health care services for sexually active youth, including voluntary HIV-1 counseling and testing.<\/jats:p>","DOI":"10.1542\/peds.2005-2750","type":"journal-article","created":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T19:21:17Z","timestamp":1138821677000},"page":"566-571","source":"Crossref","is-referenced-by-count":12,"title":["Reducing the Risk of HIV Infection Associated With Illicit Drug Use"],"prefix":"10.1542","volume":"117","author":[{"name":"Committee on Pediatric AIDS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2006,2,1]]},"reference":[{"key":"2023092514003915000_R1","unstructured":"Centers for Disease Control and Prevention. HIV\/AIDS surveillance report 2002. Available at: www.cdc.gov\/hiv\/stats\/hasr1402\/2002surveillancereport.pdf. Accessed August 5, 2004"},{"key":"2023092514003915000_R2","unstructured":"National Institute of Allergy and Infectious Diseases. HIV Infection in Adolescents: Fact Sheet. Rockville, MD: National Institutes of Health;2004. Available at: www.niaid.nih.gov\/factsheets\/hivadolescent.htm. Accessed August 5, 2004"},{"key":"2023092514003915000_R3","doi-asserted-by":"crossref","unstructured":"Futterman D, Chabon B, Hoffman ND. HIV and AIDS in adolescents. Pediatr Clin North Am.\u20082000;47:171\u2013188","DOI":"10.1016\/S0031-3955(05)70200-5"},{"key":"2023092514003915000_R4","unstructured":"Garofalo R, Harper GW. Not all adolescents are the same: addressing the unique needs of gay and bisexual male youth. Adolesc Med.\u20082003;14:595\u2013611, vi"},{"key":"2023092514003915000_R5","doi-asserted-by":"crossref","unstructured":"Valleroy LA, MacKellar DA, Karon JM, et al. HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA.\u20082000;284:198\u2013204","DOI":"10.1001\/jama.284.2.198"},{"key":"2023092514003915000_R6","unstructured":"Johnston LD, O'Malley PM, Bachman JG. Monitoring the Future: National Survey Results on Drug Use, 1975\u20132002. Volume I: Secondary School Students. Bethesda, MD: National Institute on Drug Abuse;2003. NIH Publication 03-5375"},{"key":"2023092514003915000_R7","doi-asserted-by":"crossref","unstructured":"Lynskey MT, Heath AC, Bucholz KK, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA.\u20082003;289:427\u2013433","DOI":"10.1001\/jama.289.4.427"},{"key":"2023092514003915000_R8","doi-asserted-by":"crossref","unstructured":"Staton M, Leukefeld C, Logan TK, et al. Risky sex behavior and substance use among young adults. Health Soc Work.\u20081999;24:147\u2013154","DOI":"10.1093\/hsw\/24.2.147"},{"key":"2023092514003915000_R9","doi-asserted-by":"crossref","unstructured":"Clark DB, DeBellis MD, Lynch KG, Cornelius JR, Martin CS. Physical and sexual abuse, depression and alcohol use disorders in adolescents: onsets and outcomes. Drug Alcohol Depend.\u20082003;69:51\u201360","DOI":"10.1016\/S0376-8716(02)00254-5"},{"key":"2023092514003915000_R10","doi-asserted-by":"crossref","unstructured":"Carroll ST, Riffenburgh RH, Roberts TA, Myhre EB. Tattoos and body piercings as indicators of adolescent risk-taking behaviors. Pediatrics.\u20082002;109:1021\u20131027","DOI":"10.1542\/peds.109.6.1021"},{"key":"2023092514003915000_R11","doi-asserted-by":"crossref","unstructured":"Roberts TA, Ryan SA. Tattooing and high-risk behavior in adolescents. Pediatrics.\u20082002;110:1058\u20131063","DOI":"10.1542\/peds.110.6.1058"},{"key":"2023092514003915000_R12","doi-asserted-by":"crossref","unstructured":"Brooks TL, Woods ER, Knight SR, Shrier LA. Body modification and substance use in adolescents: is there a link?J Adolesc Health.\u20082003;32:44\u201349","DOI":"10.1016\/S1054-139X(02)00446-9"},{"key":"2023092514003915000_R13","doi-asserted-by":"crossref","unstructured":"Kendler KS, Bulik CM, Silberg J, Hettema JM, Myers J, Prescott CA. Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiologic and cotwin control analysis. Arch Gen Psychiatry.\u20082001;57:953\u2013959","DOI":"10.1001\/archpsyc.57.10.953"},{"key":"2023092514003915000_R14","doi-asserted-by":"crossref","unstructured":"Clatts MC, Goldsamt L, Neaigus A, Welle DL. The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research. J Urban Health.\u20082003;80(4 suppl 3):iii26\u2013iii39","DOI":"10.1093\/jurban\/jtg080"},{"key":"2023092514003915000_R15","doi-asserted-by":"crossref","unstructured":"Simkin DR. Adolescent substance use disorders and comorbidity. Pediatr Clin North Am.\u20082002;49:463\u2013477","DOI":"10.1016\/S0031-3955(01)00014-1"},{"key":"2023092514003915000_R16","doi-asserted-by":"crossref","unstructured":"Greydanus DE, Patel DR. Substance abuse in adolescents: a complex conundrum for the clinician. Pediatr Clin North Am.\u20082003;50:1179\u20131223","DOI":"10.1016\/S0031-3955(03)00079-8"},{"key":"2023092514003915000_R17","doi-asserted-by":"crossref","unstructured":"Cohen E, Mackenzie RG, Yates GL. HEADSS, a psychosocial risk assessment instrument: implications for designing effective intervention programs for runaway youth. J Adolesc Health.\u20081991;12:539\u2013544","DOI":"10.1016\/0197-0070(91)90084-Y"},{"key":"2023092514003915000_R18","doi-asserted-by":"crossref","unstructured":"Ehrman WG, Matson SC. Approach to assessing adolescents on serious or sensitive issues. Pediatr Clin North Am.\u20081998;45:189\u2013204","DOI":"10.1016\/S0031-3955(05)70589-7"},{"key":"2023092514003915000_R19","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Substance Abuse. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention and management of substance abuse. Pediatrics.\u20081998;101:125\u2013128","DOI":"10.1542\/peds.101.1.125"},{"key":"2023092514003915000_R20","doi-asserted-by":"crossref","unstructured":"Killebrew M, Garofalo R. Talking to teens about sex, sexuality, and sexually transmitted infections. Pediatr Ann.\u20082002;31:566\u2013572","DOI":"10.3928\/0090-4481-20020901-09"},{"key":"2023092514003915000_R21","doi-asserted-by":"crossref","unstructured":"Duncan P, Dixon RR, Carlson J. Childhood and adolescent sexuality. Pediatr Clin North Am.\u20082003;50:765\u2013780","DOI":"10.1016\/S0031-3955(03)00068-3"},{"key":"2023092514003915000_R22","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Psychosocial Aspects of Child and Family Health and Committee on Adolescence. Sexuality education for children and adolescents. Pediatrics.\u20082001;108:498\u2013502","DOI":"10.1542\/peds.108.2.498"},{"key":"2023092514003915000_R23","doi-asserted-by":"crossref","unstructured":"Frankowski BL; American Academy of Pediatrics, Committee on Adolescence. Sexual orientation and adolescents. Pediatrics.\u20082004;113:1827\u20131832","DOI":"10.1542\/peds.113.6.1827"},{"key":"2023092514003915000_R24","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Adolescents. Condom use by adolescents. Pediatrics.\u20082001;107:1463\u20131469","DOI":"10.1542\/peds.107.6.1463"},{"key":"2023092514003915000_R25","doi-asserted-by":"crossref","unstructured":"Jackson S, Hafemeister TL. Impact of parental consent and notification policies on the decisions of adolescents to be tested for HIV. J Adolesc Health.\u20082001;29:81\u201393","DOI":"10.1016\/S1054-139X(00)00178-6"},{"key":"2023092514003915000_R26","doi-asserted-by":"crossref","unstructured":"Sigman G, Silber TJ, English A, Epner JE. Confidential health care for adolescents: position paper of the Society for Adolescent Medicine. J Adolesc Health.\u20081997;21:408\u2013415","DOI":"10.1016\/S1054-139X(97)00171-7"},{"key":"2023092514003915000_R27","doi-asserted-by":"crossref","unstructured":"Dasinger LK, Shane PA, Martinovich Z. Assessing the effectiveness of community-based substance abuse treatment for adolescents. J Psychoactive Drugs.\u20082004;36:27\u201333","DOI":"10.1080\/02791072.2004.10399721"},{"key":"2023092514003915000_R28","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Child Health Financing and Committee on Substance Abuse. Improving substance abuse prevention, assessment, and treatment financing for children and adolescents. Pediatrics.\u20082001;108:1025\u20131029","DOI":"10.1542\/peds.108.4.1025"},{"key":"2023092514003915000_R29","unstructured":"Drug and Alcohol Services Information System Report. Facilities Primarily Serving Adolescents: 2002. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration;2003"},{"key":"2023092514003915000_R30","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics. Insurance coverage of mental health and substance abuse services for children and adolescents: a consensus statement. Pediatrics.\u20082000;106:860\u2013862","DOI":"10.1542\/peds.106.4.860"},{"key":"2023092514003915000_R31","unstructured":"Academy for Educational Development and Centers for Disease Control and Prevention. HIV Prevention Among Drug Users: A Resource Book for Community Planners and Program Managers. Atlanta, GA: Centers for Disease Control and Prevention;1997. Available at: www.cdc.gov\/idu\/pubs\/hpdu\/hpdu.pdf. Accessed August 5, 2004"},{"key":"2023092514003915000_R32","doi-asserted-by":"crossref","unstructured":"Abdala N, Crowe M, Tolstov Y, Heimer R. Survival of human immunodeficiency virus type 1 after rinsing injection syringes with different cleaning solutions. Subst Use Misuse.\u20082004;39:581\u2013600","DOI":"10.1081\/JA-120030059"},{"key":"2023092514003915000_R33","unstructured":"Infectious Diseases Society of America. Policy Statement on Syringe Exchange, Prescribing and Paraphernalia Laws. Alexandria, VA: Infectious Diseases Society of America;2001"},{"key":"2023092514003915000_R34","unstructured":"Centers for Disease Control and Prevention. Update: syringe exchange programs\u2014United States, 1998 [published correction appears in MMWR Morb Mortal Wkly Rep. 2001;50:427]. MMWR Morb Mortal Wkly Rep.\u20082001;50:384\u2013387"},{"key":"2023092514003915000_R35","doi-asserted-by":"crossref","unstructured":"Burris S, Lurie P, Abrahamson D, Rich JD. Physician prescribing of sterile injection equipment to prevent HIV infection: time for action. Ann Intern Med.\u20082000;133:218\u2013226","DOI":"10.7326\/0003-4819-133-3-200008010-00015"},{"key":"2023092514003915000_R36","doi-asserted-by":"crossref","unstructured":"Rich JD, Macalino GE, McKenzie M, Taylor LE, Burris S. Syringe prescription to prevent HIV infection in Rhode Island: a case study. Am J Public Health.\u20082001;91:699\u2013700","DOI":"10.2105\/AJPH.91.5.699"},{"key":"2023092514003915000_R37","doi-asserted-by":"crossref","unstructured":"Yoast R, Williams MA, Deitchman SD, Champion HC. Report of the Council on Scientific Affairs: methadone maintenance and needle-exchange programs to reduce the medical and public health consequences of drug abuse. J Addict Dis.\u20082001;20(2):15\u201340","DOI":"10.1300\/J069v20n02_03"},{"key":"2023092514003915000_R38","doi-asserted-by":"crossref","unstructured":"Des Jarlais DC. Structural interventions to reduce HIV transmission among injecting drug users. AIDS.\u20082000;14(suppl 1):S41\u2013S46","DOI":"10.1097\/00002030-200006001-00006"},{"key":"2023092514003915000_R39","doi-asserted-by":"crossref","unstructured":"Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr.\u20082002;31:237\u2013242","DOI":"10.1097\/00126334-200210010-00015"},{"key":"2023092514003915000_R40","doi-asserted-by":"crossref","unstructured":"Amundsen EJ, Eskild A, Stigum H, Smith E, Aalen OO. Legal access to needles and syringes\/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: a comparative study of Denmark, Norway and Sweden. Eur J Public Health.\u20082003;13:252\u2013258","DOI":"10.1093\/eurpub\/13.3.252"},{"key":"2023092514003915000_R41","doi-asserted-by":"crossref","unstructured":"Semaan S, Des Jarlais DC, Sogolow E, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr.\u20082002;30(suppl 1):S73\u2013S93","DOI":"10.1097\/00042560-200207011-00008"},{"key":"2023092514003915000_R42","doi-asserted-by":"crossref","unstructured":"Junge B, Valente T, Latkin C, Riley E, Vlahov D. Syringe exchange not associated with social network formation: results from Baltimore. AIDS.\u20082000;14:423\u2013426","DOI":"10.1097\/00002030-200003100-00016"},{"key":"2023092514003915000_R43","doi-asserted-by":"crossref","unstructured":"Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol.\u20082001;154(12 suppl):S70\u2013S77","DOI":"10.1093\/aje\/154.12.S70"},{"key":"2023092514003915000_R44","unstructured":"Centers for Disease Control and Prevention. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. MMWR Recomm Rep.\u20081998;47(RR-17):1\u201314"},{"key":"2023092514003915000_R45","doi-asserted-by":"crossref","unstructured":"Lurie P, Miller S, Hecht F, Chesney M, Lo B. Postexposure prophylaxis after nonoccupation HIV exposure: clinical, ethical, and policy considerations. JAMA.\u20081998;280:1769\u20131773","DOI":"10.1001\/jama.280.20.1769"},{"key":"2023092514003915000_R46","unstructured":"Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV recommendations for postexposure prophylaxis. MMWR Recomm Rep.\u20082001;50(RR-11):1\u201352"},{"key":"2023092514003915000_R47","doi-asserted-by":"crossref","unstructured":"Havens PL; American Academy of Pediatrics, Committee on Pediatric AIDS. Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics.\u20082003;111:1475\u20131489","DOI":"10.1542\/peds.111.6.1475"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/2\/566\/1531370\/zpe00206000566.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/2\/566\/1531370\/zpe00206000566.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T14:01:15Z","timestamp":1695650475000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/2\/566\/68458\/Reducing-the-Risk-of-HIV-Infection-Associated-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,2,1]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-2750","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}